Showing results (61-70 of 277) with videos related to
Sort By:
Pageof 28
Journal of Cardiovascular Pharmacology and Therapeutics|September 17, 2013
Pharmacologic therapy that simulates conditioning for cardiac ischemic/reperfusion injuryVivek Sivaraman, Derek M YellonInternational Journal of Cardiology|November 20, 2016
A new era in the management of type 2 diabetes: Is cardioprotection at long last a reality?Xavier Rossello, Derek M YellonBasic Research in Cardiology|December 15, 2007
Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore openingGurpreet S Bhamra, Derek J Hausenloy, Sean M Davidson, et al.Cardiovascular Research|May 6, 2008
Remote ischaemic preconditioning: underlying mechanisms and clinical applicationDerek J Hausenloy, Derek M YellonNature Reviews. Cardiology|June 22, 2011
The therapeutic potential of ischemic conditioning: an updateDerek J Hausenloy, Derek M YellonCardiovascular Drugs and Therapy|May 25, 2010
The second window of preconditioning (SWOP) where are we now?Derek J Hausenloy, Derek M YellonCurrent Opinion in Cardiology|July 4, 2009
Enhancing cardiovascular disease risk reduction: raising high-density lipoprotein levelsDerek J Hausenloy, Derek M YellonCardiovascular Research|February 14, 2004
New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathwayDerek J Hausenloy, Derek M YellonNature Clinical Practice. Cardiovascular Medicine|November 1, 2005
Realizing the clinical potential of ischemic preconditioning and postconditioningDerek M Yellon, Derek J HausenloyPharmacology & Therapeutics|August 8, 2007
Preconditioning and postconditioning: united at reperfusionDerek J Hausenloy, Derek M YellonPageof 28